ViaFarma Solutions Request quote

ViaFarma service

eCTD, Artwork & Label Compliance

Technical dossier preparation, eCTD conversion and review, compliant artwork, labels and multilingual healthcare materials.

Dossier readiness

We organize, review and convert CTD or paper files into a submission-ready eCTD structure, identifying gaps before filing.

Artwork and localization

Labels, leaflets and promotional materials are checked for consistency, readability and Arabic-English requirements.

A clear scope before quoting

Who this service is for

Regulatory teams, MAHs and manufacturers preparing or correcting UAE eCTD submissions, technical sequences, labelling or artwork.

Typical situations

  • The dossier needs content and structure readiness review
  • A sequence has technical validation findings
  • Labels, leaflets or artwork require UAE/GCC alignment

Potential scope

  • Dossier-content and gap review
  • eCTD structure, conversion and technical validation support
  • Validation-finding analysis and correction coordination
  • Artwork, labelling and leaflet compliance review

Deliverables

  • Readiness findings and prioritised actions
  • Technical sequence or correction plan
  • Consolidated artwork and labelling comments

Information needed to scope the work

  • Available dossier modules and source files
  • Validation reports or authority findings
  • Current artwork, labels and reference text
  • Submission type, jurisdiction and timing

Timing and fees

Technical validation confirms that a sequence meets applicable technical criteria; it is not regulatory approval. Automated or AI-assisted checks do not replace expert regulatory review. Fees depend on file condition, modules, sequence complexity, artwork volume and timing.

Request a Proposal & Quote

eCTD technical resource

For additional information on eCTD software and technical implementation solutions, visit Masuu Global.

Masuu Global

Does your product require a bioequivalence study?

Assess the likely BE requirement and suitable center options before committing to a study, and connect the technical decision with the intended registration and dossier pathway.

Explore BE Study Support

Questions from manufacturing and regulatory teams

What are common dossier-readiness gaps?

EDE specifies eCTD for its drug and biopharmaceutical marketing authorization service. For a readiness review, ViaFarma recommends reconciling manufacturer, site and product details across modules and artwork, checking that evidence matches the proposed product, and running technical validation before submission.

Official source · Emirates Drug Establishment

Request an eCTD Readiness Review

How we start

Share the product or scope, target authority or market, and desired timing. We will return with an initial assessment and clear next steps.

Is your product ready for the UAE — beyond registration?

Free UAE Market-Entry Quick Check

Planning to introduce a pharmaceutical, medical device, healthcare or cosmetic product in the UAE? Send us your product and current approval status. The initial review can cover classification and pathway, regulatory readiness, obvious dossier gaps, market-entry considerations and a recommended next step. It is not a complete market-access assessment.

Send Product for Quick Check Book a 15-Minute ConsultationWe will review the information you send to identify the most appropriate first step.

Our approach

A clear path from assessment to execution.

01

Assess

We understand the product, objective and target authority or market.

02

Plan

We define priorities, requirements and the practical next step.

03

Deliver

We coordinate the agreed work, documents and communication.

04

Support

We stay engaged through follow-up and the project lifecycle.